Personal information

No personal information available

Activities

Collapse all

Employment (1)

Second Affiliated Hospital of Zhejiang University: Hangzhou, CN

(Center of Clinical Pharmacology)
Employment
Source: Self-asserted source
Wenjun Chen

Education and qualifications (2)

Peking University: Beijing, Beijing, CN

2014-08 to 2019-06
Education
Source: Self-asserted source
Wenjun Chen

Xi'an Jiaotong University: Xi'an, Shaanxi, CN

2010-08 to 2014-07
Education
Source: Self-asserted source
Wenjun Chen

Works (7)

Physiologically based pharmacokinetic modeling to characterize enterohepatic recirculation and predict food effect on the pharmacokinetics of hyzetimibe.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2023-09-06 | Journal article
DOI: 10.1016/j.ejps.2023.106576
PMID: 37678518
Contributors: Chen W; Ruan Z; Honggang Lou; Yang D; Chen J; Shao R; Jiang B
Source: Self-asserted source
Wenjun Chen

Safety, pharmacokinetics and exploratory exposure-response analysis of CX3002, a novel inhibitor of Xa, in Chinese healthy subjects.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
2023-03-27 | Journal article
DOI: 10.1016/j.ejps.2023.106437
PMID: 36990295
Contributors: Chen W; Ruan Z; Honggang Lou; Wang L; Shao R; Li F; Jiang B
Source: Self-asserted source
Wenjun Chen

Population pharmacokinetics and enterohepatic recirculation of hyzetimibe and its main metabolite in Chinese healthy subjects.

British journal of clinical pharmacology
2022-02-07 | Journal article | Author
DOI: 10.1111/bcp.15187
PMID: 34931372
Contributors: Wenjun Chen; Ruan Z; Jinliang Chen; Yang D; Shao R; Honggang Lou; Jiang B
Source: Self-asserted source
Wenjun Chen

Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review.

Asian journal of andrology
2021-03-01 | Journal article
DOI: 10.4103/aja.aja_53_20
PMID: 33159024
PMC: PMC7991808
Source: Self-asserted source
Wenjun Chen

Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer.

European journal of clinical pharmacology
2020-01-10 | Journal article
DOI: 10.1007/s00228-020-02829-9
PMID: 31925454
Source: Self-asserted source
Wenjun Chen

Evaluation of potential surrogate endpoints for prediction of overall survival in patients with castration-resistant prostate cancer: trial-level meta-analysis.

European journal of clinical pharmacology
2019-08-28 | Journal article
DOI: 10.1007/s00228-019-02736-8
PMID: 31463577
Source: Self-asserted source
Wenjun Chen

Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models.

The Journal of pharmacology and experimental therapeutics
2017-10-30 | Journal article
DOI: 10.1124/jpet.117.243931
PMID: 29084815
Source: Self-asserted source
Wenjun Chen
How many people are using ORCID?